Role of Modelling and Simulation: A European Regulatory Perspective

Author： Jönsson Siv   Henningsson Anja   Edholm Monica   Salmonson Tomas  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.51, Iss.2, 2012-02, pp. : 69-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Management: A European Regulatory Perspective

By Moseley J.N.S.  

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 499-508

Adis International

Access to resources Recommend Favorite

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B.   Smyth Rosalind L.  

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite

A Swedish Regulatory Perspective on European Risk Management

By Hedenmalm Karin   Alvan Gunnar  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 2, 2007-01 ,pp. : 131-145

Adis International

Access to resources Recommend Favorite

Non-Clinical Development of Fixed Combinations: A European Regulatory Perspective

By Ulla Liminga   Beatriz Silva Lima  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 135-138

Adis International

Access to resources Recommend Favorite

Regulatory Aspects of Pharmacokinetic Profiling in Special Populations: A European Perspective

By Edholm Monica   Eva Gil Berglund   Salmonson Tomas  

Clinical Pharmacokinetics, Vol. 47, Iss. 11, 2008-01 ,pp. : 693-701

Adis International

Access to resources Recommend Favorite